MAPK3 and melanoma: In addition, we have not reported changes in the overall protein turnover, and the association between ERK-1/2 activity and MCL-1 level was not a part of an immediate response of melanoma cells to serum because serum-induced inhibition of ERK-1/2 did not coincide with the reduction of MCL-1 at the protein level.